No Data
No Data
Lin Pinzhuo has been promoted from an independent non-executive director to an executive director of Kingmed Diagnostics (00648.HK).
On August 1, Gleamray announced that starting from August 1, 2024: (i) Lin Pinzhuo has been transferred from the company's independent non-executive director to executive director; (b) he has been transferred from the chairman of the nomination committee to a member of the nomination committee; (c) appointed as the authorized representative of the company and resigned as a member of the audit committee; (ii) Le Kewei has been appointed as an independent non-executive director of the company, chairman of the nomination committee, and member of the audit committee, remuneration committee, and risk management committee; (iii) Tang Cuihuan Has been appointed as the independent non-executive director and audit committee member of the company; (iv)
Express News | SoftMedx Healthcare - Lin Pinzhuo Re-Designated From Independent Non-Executive Director to Executive Director
Express News | SoftMedx Healthcare Ltd - Chng Wai Kwan Has Resigned as an Executive Director
Jingjukaangliao: Terminate loan capitalization agreement and continue to suspend trading.
China Healthwise (00648) announced that the company is mainly engaged in distributing medical devices and products in Hong Kong, including medical business related to dental equipment and products. All of its business operations continue as usual. On July 31, 2024, the company entered into a contract with the subscribers to terminate the loan capitalization agreement and extend the subscriber's loan maturity date to March 31, 2025. As of the date of this announcement, the plan has been successfully implemented and cash has been distributed to the planned creditors who have acknowledged their claims to the plan administrator. The board of directors will continue to monitor the impact of the suspension on the group's operations and financial performance, and take appropriate measures in a timely manner.
Kyee Medical (00648): terminated capitalization agreement for loans, still suspended.
China Jo-Jo Drugstores (00648) has released an announcement that the company mainly deals with the distribution of medical devices and products in Hong Kong, which involves dental care...
Jingjukangliao plans to discount 97.4% of its loan to Zhou Guang's YHI INTL for capitalization of shares and convertible bonds.
Jiangu Medical (00648) announced that on June 13, 2024, the company entered into a loan capitalization agreement with the subscriber. Under the agreement, the company agrees to issue loan capitalization shares and convertible notes under certain conditions to settle the subscriber's loan. Completion of the loan capitalization agreement depends on, among other things, the conversion of loans under the restructuring agreement. Under the loan capitalization agreement, the subscriber will subscribe to 9 billion loan capitalization shares at a price of HKD 0.01 per share and HKD 6 million principal convertible notes, which can be converted at a price of HKD 0.01 per share.
No Data